Pacific Biosciences Of California(FRA) P09

Market Cap€370.04M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€1.14

-4.33%

-0.05Today

Pacific Biosciences Of California Financials at a Glance

Market Cap

€370.04M

Revenue (TTM)

€136.58

Net Income (TTM)

-€112.75

EPS (TTM)

-€0.37

P/E Ratio

-3.22

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Price

€1.14

Volume

Open

€1.14

Price

€1.14

Volume

Open

€1.14

Previous Close

€1.19

Daily Range

€1.14 - €1.14

52-Week Range

€0.93 - €2.30

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Price

€1.14

Volume

Open

€1.14

Previous Close

€1.19

Daily Range

€1.14 - €1.14

52-Week Range

€0.93 - €2.30

Estimated Earnings Date

N/A

P09 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pacific Biosciences Of California

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

485

CEO

Christian O. Henry, MBA

Website

www.pacb.com

P09 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-966.52%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-31.06%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€370.04M

Shares Outstanding

310.83M

Volume

Avg. Volume

685.167

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Pacific Biosciences Of California Performance Analysis

Pacific Biosciences Of California annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 122,081,004	10.6%
2023	2023-12-31	EUR 185,476,002	51.9%
2024	2024-12-31	EUR 142,382,653	-23.2%
2025	2025-12-31	EUR 141,775,763	-0.4%

Pacific Biosciences Of California annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -1.33	77.3%
2023	2023-12-31	EUR -1.12	-16.0%
2024	2024-12-31	EUR -1.47	31.2%
2025	2025-12-31	EUR -1.61	10.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€33.55

+1.0%

Gross Profit

€10.15

+0.6%

Gross Margin

30.26%

+0.7%

Market Cap

€370.04M

N/A

Market Cap/Employee

€0.95

N/A

Employees

485

N/A

Net Income

-€38.48

+1.0%

EBITDA

-€34.93

+2.2%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€671.01

+4.4%

Total Debt

€617.62

+1.0%

Accounts Receivable

€27.21

+1.0%

Inventory

€53.43

+1.2%

Long Term Debt

€616.42

+1.0%

Short Term Debt

€1.20

+2.0%

Return on Assets

-16.57%

+0.4%

Return on Invested Capital

-31.27%

+2.3%

Free Cash Flow

-€32.19

+1.4%

Operating Cash Flow

-€30.84

+1.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.92+0.00%

WETOWetour Robotics

WETOWetour Robotics$5.48-0.04%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$44.67+0.02%

INTCIntel

INTCIntel$89.51+0.00%

NVDANvidia

NVDANvidia$220.78+0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

SNAPSnap

SNAPSnap$5.55+0.02%

Questions About P09

What is the current price of Pacific Biosciences Of California?

Pacific Biosciences Of California is trading at €1.14 per share.

What is the 52-week range for Pacific Biosciences Of California?

Over the past 52 weeks, Pacific Biosciences Of California has traded between €0.93 and €2.30.

How much debt does Pacific Biosciences Of California have?

As of the most recent reporting period, Pacific Biosciences Of California reported total debt of €617.62M.

How much cash does Pacific Biosciences Of California have on hand?

Pacific Biosciences Of California reported €53.39M in cash and cash equivalents in its most recent financial results.

What is Pacific Biosciences Of California’s dividend yield?

Pacific Biosciences Of California does not currently have a dividend yield.

Pacific Biosciences Of California(FRA) P09

Pacific Biosciences Of California Financials at a Glance

P09 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Pacific Biosciences Of California

P09 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Pacific Biosciences Of California Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About P09

What is the current price of Pacific Biosciences Of California?

What is the 52-week range for Pacific Biosciences Of California?

How much debt does Pacific Biosciences Of California have?

How much cash does Pacific Biosciences Of California have on hand?

What is Pacific Biosciences Of California’s dividend yield?

Premium Investing Services